Dataset Information

A TLR-inducible Cyclin J regulates inflammatory and anti-tumor responses by suppressing macrophage glycolysis via CDKs

ABSTRACT: Proteome and phosphoproteome analyses were performed to identify CDK substrates whose phosphorylation is induced by Cyclin J in macrophages. In the first experiment, RAW264.7 cells synchronized in G2/M phase by Nocodazole were treated with CDK inhibitors, Flavopiridol or Roscovitine, followed by phosphoproteomics. In the second experiment, proteome and phosphoproteome analyses were performed to characterize RAW264.7 cells inducibly expressing Cyclin J.

ORGANISM(S): Mus Musculus (mouse)

SUBMITTER: Osamu Takeuchi

PROVIDER: PXD021176 | JPOST Repository | Sat Aug 28 00:00:00 BST 2021

REPOSITORIES: jPOST

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	Phosphoproteomics_RAW264.7_CDK%20inhibitors.txt	Txt
	Phosphoproteomics_RAW264.7_CDK%20inhibitors_fr1.raw	Raw
	Phosphoproteomics_RAW264.7_CDK%20inhibitors_fr2.raw	Raw
	Phosphoproteomics_RAW264.7_CDK%20inhibitors_fr3.raw	Raw
	Phosphoproteomics_RAW264.7_CDK%20inhibitors_fr4.raw	Raw

Items per page:

1 - 5 of 20

Similar Datasets

Project description:Progesterone receptor (PR) and its co-activators are direct targets of activated cyclin dependent kinases (CDKs) in response to peptide growth factors, progesterone, and deregulation of cell cycle inhibitors. Herein, using the T47D breast cancer model, we probed mechanisms of cell cycle-dependent PR action. In the absence of exogenous progestin, PR is specifically phosphorylated during the G2/M phase. Accordingly, numerous PR target genes are cell cycle regulated, including HSPB8, a heat-shock protein whose high expression is associated with tamoxifen-resistance. Progestin-induced HSPB8 expression required cyclin D1 and was insensitive to anti-estrogens, but blocked by anti-progestins or inhibition of specificity factor 1 (SP1). HSPB8 expression increased with or without ligand when cells were G2/M synchronized or contained high levels of cyclin D1. Knock-down of PR abrogated ligand-independent HSPB8 expression in synchronized cells. Notably, PR and cyclin D1 co-purified in whole cell lysates of transiently transfected COS-1 cells and in PR-positive T47D breast cancer cells expressing endogenous cyclin D1. PR, cyclin D1, and SP1 were recruited to the HSPB8 promoter in progestin-treated T47D breast cancer cells. Mutation of PR Ser345 to Ala (S345A) or inhibition of CDK2 activity using roscovitine disrupted PR/cyclin D1 interactions with DNA and blocked HSPB8 mRNA expression. Interaction of phosphorylated PRs with SP1 and cyclin D1 provides a mechanism for targeting transcriptionally active PRs to selected gene promoters relevant to breast cancer progression. Understanding the functional linkage between PR and cell cycle regulatory proteins will provide keys to targeting novel PR/cyclin D1 cross-talk in both hormone-responsive and HSPB8-high refractory disease. The study contains 4 different sample groups measured in triplicate, for a total of 12 individual samples (12 arrays). In T47D human breast cancer cell lines stably expressing PR-B, cells were synchronized (or not synchronized) before G2/M phase using nocodazole. These cell lines (synchronized or not synchronized) were treated with either (1) vehicle control (ethanol) or (2) PR ligand R5020 10e-8 M for 6 hours before total RNA harvest. Thus, the experiment contains two cell lines, and two treatments (4 sample groups) treated and analyzed in triplicate (12 microarrays). Standard Illumina HT-12v4 chip controls were used during hybridization.

Dataset Information

A TLR-inducible Cyclin J regulates inflammatory and anti-tumor responses by suppressing macrophage glycolysis via CDKs

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets